{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:11Z","timestamp":1786119311686,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/qai.0b013e318198a619","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T08:39:40Z","timestamp":1242895180000},"page":"381-389","source":"Crossref","is-referenced-by-count":7,"title":["Relationship of Injection Drug Use, Antiretroviral Therapy Resistance, and Genetic Diversity in the HIV-1 pol Gene"],"prefix":"10.1097","volume":"50","author":[{"given":"Jeanne","family":"Kowalski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Gange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Ling","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Templeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujia","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Fen","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B","family":"Markham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20210131","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00126334-200401010-00006","article-title":"Differences in HIV disease progression by injecting drug use in HIV-infected persons in care.","volume":"35","author":"Moore","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-6-20210131","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/01.qai.0000214805.52723.c1","article-title":"Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing.","volume":"41","author":"Oette","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-6-20210131","first-page":"92","article-title":"Drug resistance mutations in HIV-1.","volume":"11","author":"DAquila","year":"2003","journal-title":"Top HIV Med"},{"key":"R5-6-20210131","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1128\/JCM.41.4.1594-1599.2003","article-title":"Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System.","volume":"41","author":"Kuritzkes","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R6-6-20210131","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/JCM.41.4.1586-1593.2003","article-title":"Accuracy of the TRUGENE HIV-1 genotyping kit.","volume":"41","author":"Grant","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R7-6-20210131","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1128\/JVI.76.4.1753-1761.2002","article-title":"Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection.","volume":"76","author":"Brenner","year":"2002","journal-title":"J Virol"},{"key":"R8-6-20210131","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1086\/515282","article-title":"Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance.","volume":"177","author":"Maeda","year":"1998","journal-title":"J Infect Dis"},{"key":"R9-6-20210131","doi-asserted-by":"crossref","first-page":"10958","DOI":"10.1128\/JVI.74.23.10958-10964.2000","article-title":"Relative replication fitness of a high-level 3-azido-3-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr-Gly) at codon 69.","volume":"74","author":"Imamichi","year":"2000","journal-title":"J Virol"},{"key":"R10-6-20210131","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1128\/JVI.79.15.9625-9634.2005","article-title":"Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.","volume":"79","author":"Tobin","year":"2005","journal-title":"J Virol"},{"key":"R11-6-20210131","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.qai.0000174652.40782.4e","article-title":"Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure.","volume":"41","author":"Gange","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R12-6-20210131","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1086\/315044","article-title":"The effect of drug-injection behavior on genetic evolution of HIV-1.","volume":"180","author":"Carneiro","year":"1999","journal-title":"J Infect Dis"},{"key":"R13-6-20210131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001648-199803000-00004","article-title":"The Womens Interagency HIV Study. WIHS Collaborative Study Group.","volume":"9","author":"Barkan","year":"1998","journal-title":"Epidemiology"},{"key":"R14-6-20210131","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1128\/JVI.70.8.5720-5730.1996","article-title":"Maintaining the integrity of human immunodeficiency virus sequence databases.","volume":"70","author":"Learn","year":"1996","journal-title":"J Virol"},{"key":"R15-6-20210131","doi-asserted-by":"crossref","first-page":"12568","DOI":"10.1073\/pnas.95.21.12568","article-title":"Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline.","volume":"95","author":"Markham","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-6-20210131","first-page":"215","article-title":"Drug resistance mutations in HIV-1.","volume":"11","author":"Johnson","year":"2003","journal-title":"Top HIV Med"},{"key":"R17-6-20210131","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1198\/016214502760046952","article-title":"A nonparametric test of gene region heterogeneity associated with phenotype.","volume":"97","author":"Kowalski","year":"2002","journal-title":"J Am Stat Assoc"},{"key":"R20-6-20210131","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/sim.4780111304","article-title":"Repeated measures in clincial trials; analysis using mean summary statistics and its implications for design.","volume":"11","author":"Liang","year":"1992","journal-title":"Stat Med"},{"key":"R21-6-20210131","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/135965350801300212","article-title":"Prevalence, genotypic associations and phenotypic characterization of K65R, L74V and other HIV-1 RT resistance mutations in a commercial database.","volume":"13","author":"McColl","year":"2008","journal-title":"Antivir Ther"},{"key":"R22-6-20210131","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1128\/JVI.02579-07","article-title":"Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.","volume":"82","author":"Little","year":"2008","journal-title":"J Virol"},{"key":"R23-6-20210131","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jmv.21085","article-title":"HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy.","volume":"80","author":"Gianotti","year":"2008","journal-title":"J Med Virol"},{"key":"R24-6-20210131","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1097\/QAD.0b013e3282ef1bc8","article-title":"Virological fitness of HIV in patients with resistance to enfuvirtide.","volume":"21","author":"Chibo","year":"2007","journal-title":"AIDS"},{"key":"R25-6-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.10269","article-title":"Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.","volume":"69","author":"Nicastri","year":"2003","journal-title":"J Med Virol"},{"key":"R26-6-20210131","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.qai.0000219787.65915.56","article-title":"An increase in viral replicative capacity drives the evolution of protease inhibitor-resistant human immunodeficiency virus type 1 in the absence of drugs.","volume":"42","author":"van Maarseveen","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R27-6-20210131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4615-2980-4_26","article-title":"Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection.","volume":"335","author":"Peterson","year":"1993","journal-title":"Adv Exp Med Biol"},{"key":"R28-6-20210131","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/jim-50-06-03","article-title":"Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor.","volume":"50","author":"Guo","year":"2002","journal-title":"J Investig Med"},{"key":"R29-6-20210131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0042-6822(03)00015-1","article-title":"Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.","volume":"309","author":"Steele","year":"2003","journal-title":"Virology"},{"key":"R30-6-20210131","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1537-2995.1996.361097017170.x","article-title":"Human immunodeficiency virus type 1 activation after blood transfusion.","volume":"36","author":"Mudido","year":"1996","journal-title":"Transfusion"},{"key":"R31-6-20210131","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(94)91110-X","article-title":"Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1.","volume":"343","author":"Heng","year":"1994","journal-title":"Lancet"},{"key":"R32-6-20210131","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.V86.3.1082.1082","article-title":"Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination.","volume":"86","author":"OBrien","year":"1995","journal-title":"Blood"},{"key":"R33-6-20210131","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1086\/315260","article-title":"Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.","volume":"181","author":"Gunthard","year":"2000","journal-title":"J Infect Dis"},{"key":"R34-6-20210131","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JCM.43.1.406-413.2005","article-title":"Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.","volume":"43","author":"Palmer","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R35-6-20210131","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/10872910252806117","article-title":"Factors related to virologic failure among HIV-positive injecting drug users treated with combination antiretroviral therapy including two nucleoside reverse transcriptase inhibitors and nevirapine.","volume":"16","author":"Zaccarelli","year":"2002","journal-title":"AIDS Patient Care STDS"},{"key":"R36-6-20210131","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/378301","article-title":"Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.","volume":"37","author":"Sethi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R37-6-20210131","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00002030-200106150-00006","article-title":"Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy.","volume":"15","author":"Poundstone","year":"2001","journal-title":"AIDS"},{"key":"R38-6-20210131","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/01.aids.0000176219.48484.f1","article-title":"Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use.","volume":"19","author":"Wood","year":"2005","journal-title":"AIDS"},{"key":"R39-6-20210131","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/00002030-199905280-00015","article-title":"Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users.","volume":"13","author":"Alexander","year":"1999","journal-title":"AIDS"},{"key":"R40-6-20210131","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jama.280.6.544","article-title":"Self-reported antiretroviral therapy in injection drug users.","volume":"280","author":"Celentano","year":"1998","journal-title":"JAMA"},{"key":"R41-6-20210131","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jama.280.6.547","article-title":"Barriers to use of free antiretroviral therapy in injection drug users.","volume":"280","author":"Strathdee","year":"1998","journal-title":"JAMA"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-200904010-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:52:49Z","timestamp":1786038769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200904010-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318198a619","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}